Pediatric acute disseminated encephalomyelitis following asymptomatic coronavirus disease 2019
Yuta Nakamura1, Takahiro Namba1, Yukiko Kawazu1
1Department of Pediatrics, Fukuyama City Hospital, Fukuyama, Japan.
Insights
A 5-year-old boy developed acute disseminated encephalomyelitis (ADEM) during a subacute, asymptomatic infection with SARS-CoV-2. This case highlights ADEM as a potential neurological complication of COVID-19, even without acute symptoms.
Area of Science:
- Neurology
- Infectious Diseases
- Pediatrics
Background:
- The emergence of SARS-CoV-2 has led to widespread outbreaks of COVID-19.
- Neurological complications, including central nervous system (CNS) involvement, can occur in patients with severe COVID-19 during the acute phase.
Observation:
- A 5-year-old boy presented with acute disseminated encephalomyelitis (ADEM) with initial symptoms of dysphoria and right lower extremity pain.
- The patient had no fever or respiratory symptoms during the episode.
- Brain and spinal MRI revealed extensive white matter lesions and central gray matter lesions, respectively.
- Tests were negative for aquaporin-4 antibodies but positive for myelin oligodendrocyte glycoprotein antibodies.
- A nasopharyngeal swab was positive for SARS-CoV-2 via PCR.
Findings:
- This case represents the first reported instance of ADEM in the subacute phase of COVID-19 in a patient lacking acute symptoms.
- The findings suggest that ADEM can be a sequela of asymptomatic SARS-CoV-2 infection.
Implications:
- ADEM should be considered in the differential diagnosis of new-onset neurological disorders, particularly in the context of COVID-19.
- This case expands the understanding of the spectrum of neurological manifestations associated with SARS-CoV-2 infection.
- Further research is warranted to elucidate the mechanisms linking SARS-CoV-2 to ADEM and to identify potential biomarkers for early detection and intervention.
Abstract:
After the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic emerged, the virus spread rapidly worldwide, and outbreaks continued to occur intermittently. Here, we present the case of a 5-year-old boy with acute disseminated encephalomyelitis (ADEM) and initial symptoms of dysphoria and pain in the right lower extremity. Around the time of this episode, the patient exhibited no fever or respiratory symptoms. Brain magnetic resonance imaging (MRI) revealed multiple T2-weighted image/fluid-attenuated inversion recovery high-signal areas bilaterally subcortical to the deep white matter, corpus callosum, and bilateral basal ganglia. MRI of the cervical and thoracic regions indicated a long lesion with continuous T2WI high signal intensity in the central gray matter. Serum aquaporin-4 antibody and serum myelin oligodendrocyte glycoprotein antibody tests were negative and positive, respectively. A polymerase chain reaction test using nasopharyngeal swab fluid upon admission was positive for SARS-CoV-2. Patients with severe coronavirus disease 2019 (COVID-19) in the acute phase may show central nervous system symptoms. There have been no previous reports of ADEM in the subacute phase of COVID-19, lacking symptoms in the acute phase, as in the present case. Notably, ADEM can develop in the subacute phase of asymptomatic COVID-19 infection.
Related Concept Videos
Viral Meningitis
Poliomyelitis
Arboviral Encephalitis
Respiratory Syncytial Virus Disease
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology


